DESCRIPTION OF CLINICAL POLYPHARMACY PRESCRIPTIONS IN TYPE 2 DIABETES MELLITUS PATIENTS AT HOSPITAL X JEMBER DISTRICT
DOI:
https://doi.org/10.36858/ipj.v1i2.29Keywords:
Recipe, Polypharmacy, Type 2 Diabetes Mellitus, Hospital.Abstract
Background: Diabetes mellitus (DM) is a metabolic disease caused by insulin resistance and pancreatic beta cell dysfunction. Polypharmacy is the use of three or more drugs every day is very common in patients with diabetes mellitus. WHO data shows that the prevalence of Diabetes Mellitus (DM) polypharmacy will reach 7.4% - 43.4% by 2023.
Objective: This study aims to determine the clinical picture of polypharmacy prescriptions in patients with type 2 diabetes mellitus at X Hospital, Jember Regency.
Method: This study used a descriptive non-experimental method by observation, involving 80 samples. Samples were selected by random sampling and data were analysed and displayed in the form of frequencies and percentages using Microsoft Excel and SPSS.
Results: The results of this study are the description of the most polypharmacy prescriptions, namely prescriptions with 3 drug items as many as 3 prescriptions (7.5%), and the description of the least polypharmacy prescriptions, namely prescriptions with 4 drug items, and prescriptions with 10 drug items as many as 1 prescription (1%). In addition, the results of this study also contained drug interactions as many as 72 interacting prescriptions.
Conclusion: From the discussion above, it can be concluded that, in the study at Hospital X, Jember Regency, polypharmacy was found from the samples analysed, all of which were polypharmacy prescriptions. This study also found that prescriptions for type 2 diabetes mellitus patients experienced drug interactions with moderate interactions being the most common. These interactions can reduce the effectiveness of treatment and increase risks for patients.
References
Hidayah, H. (2023). Evaluasi Rasionalitas Penggunaan Obat Antihipertensi Terhadap Pasien Hipertensi Di Rsud Karawang. Jurnal Buana Farma, 3(1), 7–13. https://doi.org/10.36805/jbf.v3i1.775
Kemenkes RI. (2022). Profil Kesehatan Indonesia 2021. In Pusdatin.Kemenkes.Go.Id.
Poluan, O. A., Wiyono, W. I., & Yamlean, P. V. Y. (2020). Identifikasi Potensi Interaksi Obat Pada Pasien Diabetes Melitus Tipe 2 Rawat Inap Di Rumah Sakit Gunung Maria Tomohon Periode Januari – Mei 2018. Pharmacon, 9(1), 38. https://doi.org/10.35799/pha.9.2020.27408
Rasdianah, N., & Gani, A. S. W. (2021). Interaksi Obat Pada Pasien Diabetes Melitus Tipe 2 Dengan Penyakit Penyerta Di Rumah Sakit Otanaha Kota Gorontalo. Indonesian Journal of Pharmaceutical Education, 1(1), 40–46. https://doi.org/10.37311/ijpe.v1i1.9953
Razoki, R., Ritonga, N. A. B., Sembiring, N. B., & Neswita, E. (2023). Skrining Resep Polifarmasi Secara Klinis Pada Pasien Diabetes Melitus Tipe II Di Rumah Sakit Advent. Journal of Pharmaceutical and Sciences, 6(2), 702–706. https://doi.org/10.36490/journal-jps.com.v6i2.154
Reinhard, E., Kamaluddin, M. T., & Melizah, A. (2019). Potensi Terjadinya Interaksi Obat Antidiabetik Oral Pada Pasien Diabetes Melitus Tipe 2 Usia Lanjut. Sriwijaya Journal of Medicine, 2(3), 205–210. https://doi.org/10.32539/sjm.v2i3.83
Rindarwati, A. Y., Fadillah, R. N., & Hakim, I. L. (2023). Pengaruh Edukasi Terapi Non Farmakologi pada Pasien Diabetes Melitus. Jur1. Rindarwati AY, Fadillah RN, Hakim IL. Pengaruh Edukasi Terapi Non Farmakologi Pada Pasien Diabetes Melitus. J Ilm Kesehat Delima. 2023;5(2):112–6. Nal Ilmiah Kesehatan Delima, 5(2), 112–116. https://doi.org/10.60010/jikd.v5i2.96
Risal, A., Khusna, K., & Pambudi, R. S. (2021). Interaksi Obat Hipoglikemia Oral (OHO) dengan Obat Lain pada Pasien Diabetes Mellitus Tipe II berdasarkan Farmakokinetik dan Farmakodinamik di Puskesmas Sangkrah. 1st E-Proceeding SENRIABDI 2021, 1(1), 979–990.
Saibi, Y., Hasan, D., Safitri, B., & Anwar, V. A. (2020). Potensi Hipoglikemia Dan Hiperglikemia Pada Pasien Diabetes Melitus Tipe 2 Akibat Interaksi Obat. Jurnal Ilmiah Ibnu Sina (JIIS) Ilmu Farmasi Dan Kesehatan, 5(2), 258–267. https://doi.org/10.36387/jiis.v5i2.468
Samiyah, M. (2017). Identifikasi Drug Related Problem (DRPs) Pada Pasien Diabetes Mellitus yang disertai Dengan Gagal Ginjal Kronik (Chronic Kidney Disease) di Rumah Sakit Umum Pusat (RSUP) Fatmawati (Issue 95). http://repository.uinjkt.ac.id/dspace/bitstream/123456789/33026/1/NITA FITRIANI-FKIK.pdf
Sengaji, M., Herlina, S., & Wibisono, N. (2023). Hubungan polifarmasi dengan potensi dan tingkat keparahan interaksi obat pada resep antidiabetes mellitus. Jurnal Bio Komplementer Medicine, 10(1), 1–10.
Setyoningsih, H., & Zaini, F. (2022). HUBUNGAN INTERAKSI OBAT TERHADAP EFEKTIVITAS OBAT ANTIHIPERTENSI DI RSUD dr. R. SOETRASNO REMBANG. Cendekia Journal of Pharmacy, 6(1), 76–88. https://doi.org/10.31596/cjp.v6i1.186
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Nurul Fathona
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
